Provided by Tiger Trade Technology Pte. Ltd.

Tenaya Therapeutics Inc

0.6929
+0.05298.27%
Pre-market: 0.70990.0170+2.45%04:05 EDT
Volume:3.08M
Turnover:2.13M
Market Cap:155.21M
PE:-1.30
High:0.7089
Open:0.6556
Low:0.6500
Close:0.6400
52wk High:2.35
52wk Low:0.5316
Shares:224.00M
Float Shares:223.00M
Volume Ratio:1.83
T/O Rate:1.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5333
EPS(LYR):-0.5922
ROE:-121.86%
ROA:-47.91%
PB:2.24
PE(LYR):-1.17

Loading ...

Tenaya Therapeutics granted RMAT designation from FDA for TN-401

TIPRANKS
·
Yesterday

Tenaya Wins FDA RMAT Designation for TN-401 in PKP2-Associated ARVC

Reuters
·
Yesterday

Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (Rmat) Designation for Tn-401 for the Treatment of Pkp2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

THOMSON REUTERS
·
Yesterday

Tenaya Therapeutics to Host Investor Meetings at H.C. Wainwright, Morgan Stanley Healthcare Conferences

Reuters
·
Sep 04

Analyst Reiterates Buy on Tenaya Therapeutics, Maintains $5 Price Target Amid Pipeline Progress and Extended Cash Runway

TIPRANKS
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Privia Health Group (PRVA) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Aug 07

Tenaya Therapeutics Q2 EPS $(0.20) Misses $(0.05) Estimate, Sales $1.110M Miss $10.000M Estimate

Benzinga Earnings
·
Aug 06

Tenaya Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Loss Widens on Impairment Charge

Reuters
·
Aug 06

Tenaya Net Loss Widens to $43.39 Million in Q2 FY26; R&D Expenses Slip to $16.6 Million

Reuters
·
Aug 06

Tenaya Therapeutics Q2 Net Income USD -43.393 Million

Reuters
·
Aug 06

Tenaya Therapeutics to Join Canaccord Genuity Growth Conference Fireside Chat, Investor Meetings

Reuters
·
Aug 05

Tenaya Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference

GlobeNewswire
·
Aug 05

Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bausch + Lomb Corporation (BLCO) and Curis (CRIS)

TIPRANKS
·
Jul 30

Tenaya Therapeutics CFO Eric J. Hyllengren Files Initial Beneficial Ownership Statement

Reuters
·
Jul 15

Tenaya Therapeutics Grants CFO Stock Options for 1.65 Million Shares at $0.84 Each

Reuters
·
Jul 15

Tenaya Therapeutics Grants CFO Hyllengren Options to Buy 1.65 Million Shares at $0.84 Each

Reuters
·
Jul 15

Tenaya Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 15

Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 15

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and Tenaya Therapeutics (TNYA)

TIPRANKS
·
Jul 06